Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans.

Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates

Fischer, A.G.
Endrass, T.
Reuter, M.
Kubisch, C.
Ullsperger, M.

January 2015

Contains fulltext : 142311.pdf (publisher's version ) (Open Access)Serotonin (5-HT...

The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Kerkhoven, L.A.S. van
Laheij, R.J.F.
Jansen, J.B.M.J.

January 2007

Contains fulltext : 52733.pdf (publisher's version ) (Closed access

Dosing of selective serotonin reuptake inhibitors among children and adults before and after the fda black-box warning

Bushnell, Greta A.
Stürmer, T.
Swanson, Sonja
White, Alice
Azrael, D. (Deborah)
Pate, Virginia
Miller, M. (Matthew)

March 2016

textabstractObjective: Prior research evaluated various effects of the 2004 black-box warning by the...

Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans

Peters, Marloes A M
van Faassen, Martijn
de Jong, Wilhelmina H A
Bouma, Grietje
Meijer, Coby
Walenkamp, Annemiek M E
de Vries, Elisabeth G E
Oosting, Sjoukje F
Ruhé, Henricus G
Kema, Ido

January 2020

Background: Selective serotonin reuptake inhibitors (SSRIs) block the serotonin transporter on neuro...

A study on the effects of serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

Reikvam, Anne-Grete

January 2010

Background: Several studies report that patients who use serotonin reuptake inhibitors (SRIs) to tre...

Serotonergic status in human blood

Ortiz, Jordi
Artigas, Francesc
Gelpí, Emili

January 1988

Preliminary data on the existence of a plasma pool of serotonin (5HT) in human blood has been confir...

Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines

Maher, Timothy J.
Wurtman, Richard J.

January 1999

United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Na...

Selective serotonin reuptake inhibitors and risk for gastrointestinal bleeding

Batić-Mujanović Olivera
Gavran Larisa
Černi-Obrdalj Edita

January 2014

The most of the known effects of selective serotonin reuptake inhibitors, beneficial or harmful, are...

Serotonin and its derivatives: a study on structure-activity relations

Offermeier, J.

January 1965

Contains fulltext : mmubn000001_221446338.pdf (publisher's version ) (Open Access)...

Serotonin Syndrome

Hall, Michael
Buckley, Nicholas

December 2015

Serotonin syndrome is a toxic state caused mainly by excess serotonin within the central nervous sys...

Serotonin reuptake inhibitors and cardiovascular disease

Belcher, P.R.
Drake-Holland, A.J.
Noble, M.

January 2005

Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In...

Plasma serotonin levels are associated with antidepressant response to SSRIs

Holck, Amanda
Wolkowitz, Owen M.
Mellon, Sindy H.
Reus, Victor I.
Nelson, J. Craig
Westrin, Åsa
Lindqvist, Daniel

January 2019

Background: Less than half of patients with major depressive disorder (MDD) respond to their first a...

Sustained serotonin syndrome in a treatment-resistant depressed patient during maintenance treatment with combination of three serotonergic agents

Theodoropoulou, Stavroula
Triantafyllou, Vasiliki
Konstantakopoulos, Georgios
Bellou, Evangelia
Yalouris, Athanasios

July 2019

Serotonin syndrome (SS) is a relatively rare but potentially life-threatening  condition caused...

Clinical Relevance of Linezolid-Associated Serotonin Toxicity

Woytowish, Melanie
Maynor, Lena M.

December 2016

Objective: To evaluate and review the literature surrounding serotonin toxicity in patients receivin...

Concomitant use of triptan, and SSRI or SNRI after the US food and drug administration alert on serotonin syndrome

Sclar, David A.
Robison, Linda M.
Castillo, Leigh V.
Schmidt, Jennifer M.
Bowen, Kurt A.
Oganov, Ambartsum M.
Skaer, Tracy L.
Kogut, Stephen J.

February 2012

Objective. The present study was designed to discern the prevalence of concomitant use of a 5-hydrox...

Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates

Fischer, A.G.
Endrass, T.
Reuter, M.
Kubisch, C.
Ullsperger, M.

January 2015

Contains fulltext : 142311.pdf (publisher's version ) (Open Access)Serotonin (5-HT...

The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Kerkhoven, L.A.S. van
Laheij, R.J.F.
Jansen, J.B.M.J.

January 2007

Contains fulltext : 52733.pdf (publisher's version ) (Closed access

Dosing of selective serotonin reuptake inhibitors among children and adults before and after the fda black-box warning

Bushnell, Greta A.
Stürmer, T.
Swanson, Sonja
White, Alice
Azrael, D. (Deborah)
Pate, Virginia
Miller, M. (Matthew)

March 2016

textabstractObjective: Prior research evaluated various effects of the 2004 black-box warning by the...

Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans

Peters, Marloes A M
van Faassen, Martijn
de Jong, Wilhelmina H A
Bouma, Grietje
Meijer, Coby
Walenkamp, Annemiek M E
de Vries, Elisabeth G E
Oosting, Sjoukje F
Ruhé, Henricus G
Kema, Ido

January 2020

Background: Selective serotonin reuptake inhibitors (SSRIs) block the serotonin transporter on neuro...

A study on the effects of serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

Reikvam, Anne-Grete

January 2010

Background: Several studies report that patients who use serotonin reuptake inhibitors (SRIs) to tre...

Serotonergic status in human blood

Ortiz, Jordi
Artigas, Francesc
Gelpí, Emili

January 1988

Preliminary data on the existence of a plasma pool of serotonin (5HT) in human blood has been confir...

Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines

Maher, Timothy J.
Wurtman, Richard J.

January 1999

United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH Na...

Selective serotonin reuptake inhibitors and risk for gastrointestinal bleeding

Batić-Mujanović Olivera
Gavran Larisa
Černi-Obrdalj Edita

January 2014

The most of the known effects of selective serotonin reuptake inhibitors, beneficial or harmful, are...

Serotonin and its derivatives: a study on structure-activity relations

Offermeier, J.

January 1965

Contains fulltext : mmubn000001_221446338.pdf (publisher's version ) (Open Access)...

Serotonin Syndrome

Hall, Michael
Buckley, Nicholas

December 2015

Serotonin syndrome is a toxic state caused mainly by excess serotonin within the central nervous sys...

Serotonin reuptake inhibitors and cardiovascular disease

Belcher, P.R.
Drake-Holland, A.J.
Noble, M.

January 2005

Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In...

Plasma serotonin levels are associated with antidepressant response to SSRIs

Holck, Amanda
Wolkowitz, Owen M.
Mellon, Sindy H.
Reus, Victor I.
Nelson, J. Craig
Westrin, Åsa
Lindqvist, Daniel

January 2019

Background: Less than half of patients with major depressive disorder (MDD) respond to their first a...

Sustained serotonin syndrome in a treatment-resistant depressed patient during maintenance treatment with combination of three serotonergic agents

Theodoropoulou, Stavroula
Triantafyllou, Vasiliki
Konstantakopoulos, Georgios
Bellou, Evangelia
Yalouris, Athanasios

July 2019

Serotonin syndrome (SS) is a relatively rare but potentially life-threatening  condition caused...

Clinical Relevance of Linezolid-Associated Serotonin Toxicity

Woytowish, Melanie
Maynor, Lena M.

December 2016

Objective: To evaluate and review the literature surrounding serotonin toxicity in patients receivin...

Concomitant use of triptan, and SSRI or SNRI after the US food and drug administration alert on serotonin syndrome

Sclar, David A.
Robison, Linda M.
Castillo, Leigh V.
Schmidt, Jennifer M.
Bowen, Kurt A.
Oganov, Ambartsum M.
Skaer, Tracy L.
Kogut, Stephen J.

February 2012

Objective. The present study was designed to discern the prevalence of concomitant use of a 5-hydrox...

Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates

Fischer, A.G.
Endrass, T.
Reuter, M.
Kubisch, C.
Ullsperger, M.

January 2015

Contains fulltext : 142311.pdf (publisher's version ) (Open Access)Serotonin (5-HT...

The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Kerkhoven, L.A.S. van
Laheij, R.J.F.
Jansen, J.B.M.J.

January 2007

Contains fulltext : 52733.pdf (publisher's version ) (Closed access

Dosing of selective serotonin reuptake inhibitors among children and adults before and after the fda black-box warning

Bushnell, Greta A.
Stürmer, T.
Swanson, Sonja
White, Alice
Azrael, D. (Deborah)
Pate, Virginia
Miller, M. (Matthew)

March 2016

textabstractObjective: Prior research evaluated various effects of the 2004 black-box warning by the...

Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans.

Abstract

Extracted data

Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans.

Abstract

Extracted data

Related items

Related items